161 related articles for article (PubMed ID: 7205148)
1. [Effects of rifampicin and streptomycin on the concentrations of testosterone and cortisol in the blood of men (author's transl)].
Nocke-Finck L; Breuer H; Reimers D
J Clin Chem Clin Biochem; 1980 Dec; 18(12):897-9. PubMed ID: 7205148
[TBL] [Abstract][Full Text] [Related]
2. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S
East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
[TBL] [Abstract][Full Text] [Related]
3. [Histological characteristics of tuberculous cavity treated with rifampicin--a comparative study with cases treated by primary drugs (author's transl)].
Tanaka I; Iwai K
Kekkaku; 1981 Jul; 56(7):355-60. PubMed ID: 7328996
[No Abstract] [Full Text] [Related]
4. [Deviation in cortisol metabolism induced by rifampicin. Therapeutic consequences in adrenal failure (author's transl)].
Bouchard P; Kuttenn F; Nahoul K; Mavier P; Schaison G; Mauvais-Jarvis P
Nouv Presse Med; 1979 May; 8(20):1651-4. PubMed ID: 471734
[TBL] [Abstract][Full Text] [Related]
5. Adrenal function during tuberculous infection and effects of antituberculosis treatment on endogenous and exogenous steroids.
Keven K; Uysal AR; Erdogan G
Int J Tuberc Lung Dis; 1998 May; 2(5):419-24. PubMed ID: 9613639
[TBL] [Abstract][Full Text] [Related]
6. Changes in cortisol metabolism following rifampicin therapy.
Edwards OM; Courtenay-Evans RJ; Galley JM; Hunter J; Tait AD
Lancet; 1974 Sep; 2(7880):548-51. PubMed ID: 4140269
[TBL] [Abstract][Full Text] [Related]
7. [The inactivation of glucocorticosteroid hormones by rifampicin when it is used intermittently].
Basov PV; Prokhorov NN; Spesivtsev OG
Vrach Delo; 1990 Nov; (11):20-2. PubMed ID: 2098973
[TBL] [Abstract][Full Text] [Related]
8. Study of drug resistance in previously treated tuberculosis patients in Gujarat, India.
Shah AR; Agarwal SK; Shah KV
Int J Tuberc Lung Dis; 2002 Dec; 6(12):1098-101. PubMed ID: 12546118
[TBL] [Abstract][Full Text] [Related]
9. Rifampicin reduces plasma concentrations of moxifloxacin in patients with tuberculosis.
Nijland HM; Ruslami R; Suroto AJ; Burger DM; Alisjahbana B; van Crevel R; Aarnoutse RE
Clin Infect Dis; 2007 Oct; 45(8):1001-7. PubMed ID: 17879915
[TBL] [Abstract][Full Text] [Related]
10. [The effect of rifampicin on the metabolism of glucocorticosteroid hormones in patients with tuberculosis].
Basov PV; Galćhanskaia LD; Spesivtsev OG; Khokhlova EP; Ivutina VP
Probl Tuberk; 1994; (1):21-3. PubMed ID: 8170904
[TBL] [Abstract][Full Text] [Related]
11. The effect of rifampicin on serum cortisol level in patients with active tuberculosis.
Elansary EH
Saudi Med J; 2004 Jun; 25(6):814-5. PubMed ID: 15195223
[No Abstract] [Full Text] [Related]
12. Drug resistance of Mycobacterium tuberculosis strains isolated from patients with pulmonary tuberculosis in Archangels, Russia.
Toungoussova S; Caugant DA; Sandven P; Mariandyshev AO; Bjune G
Int J Tuberc Lung Dis; 2002 May; 6(5):406-14. PubMed ID: 12019916
[TBL] [Abstract][Full Text] [Related]
13. Influence of anti-tuberculosis drug resistance on the treatment outcome of pulmonary tuberculosis patients receiving DOTS in Riyadh, Saudi Arabia.
Singla R; Al-Sharif N; Al-Sayegh MO; Osman MM; Shaikh MA
Int J Tuberc Lung Dis; 2002 Jul; 6(7):585-91. PubMed ID: 12102297
[TBL] [Abstract][Full Text] [Related]
14. Drug resistance in tuberculosis in Delhi: a 2 year profile (2001--2002).
Negi SS; Gupta S; Lal S
J Commun Dis; 2003 Jun; 35(2):74-81. PubMed ID: 15562952
[TBL] [Abstract][Full Text] [Related]
15. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis].
Kang WL; Xie YG; Tan WG; Chu NH; Li L; You YH; Yang YZ; Wang XM; Yan XL; Miao ZP; Duanmu HJ
Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883
[TBL] [Abstract][Full Text] [Related]
16. Effect of rifampicin on the pharmacokinetics of imatinib mesylate (Gleevec, STI571) in healthy subjects.
Bolton AE; Peng B; Hubert M; Krebs-Brown A; Capdeville R; Keller U; Seiberling M
Cancer Chemother Pharmacol; 2004 Feb; 53(2):102-6. PubMed ID: 14605865
[TBL] [Abstract][Full Text] [Related]
17. [Changes in drug resistance of Mycobacteria in the simultaneous use of chemotherapy and intravenous infusions of dissolved ozone].
Belianin II; Shmelev EI
Probl Tuberk Bolezn Legk; 2004; (7):32-5. PubMed ID: 15379039
[TBL] [Abstract][Full Text] [Related]
18. Detection of rifampicin-induced nephrotoxicity by N-acetyl-3-D-glucosaminidase activity.
Kumar BD; Prasad CE; Krishnaswamy K
J Trop Med Hyg; 1992 Dec; 95(6):424-7. PubMed ID: 1460703
[TBL] [Abstract][Full Text] [Related]
19. [Influence of schizophyllan, streptomycin and rifampicin on histopathological changes in mice infected with tubercle bacilli (author's transl)].
Komatsu N; Nagaoka H; Fukutome A; Ri Z; Amano H
Jpn J Antibiot; 1975 Aug; 28(4):549-57. PubMed ID: 125808
[TBL] [Abstract][Full Text] [Related]
20. Initial drug susceptibility profile of M. tuberculosis among patients under TB programme in South India.
Santha T; Thomas A; Chandrasekaran V; Selvakumar N; Gopi PG; Subramani R; Rajeswari R; Rani B; Paramasivan CN; Perumal M; Wares F; Narayanan PR
Int J Tuberc Lung Dis; 2006 Jan; 10(1):52-7. PubMed ID: 16466037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
